DELTA, British Columbia, Jan. 30, 2026 (GLOBE NEWSWIRE) — WestBond Enterprises Corporation (TSX-V: WBE) is pleased to announce that the net profit for the quarter ended December 31, 2025 increased 24.8% to $217,948 when compared to a profit of $174,630 for the three months ended September 30, 2025. Sales were $2,973,050 for the quarter ended December 31, 2025, which is 1.9% lower than $3,030,669 for the quarter ended September 30, 2025. On the hospitality/domestic side, we continue to supply customized air-laid napkins to high-profile national restaurant chains. An additional major restaurant chain has committed to our napkins and orders have already been received. Demand for our products remains high and we continue to rebrand our products to aid in our marketing efforts, which includes a proposed expansion into the retail sector. After...

GLENWOOD SPRINGS, Colo., Jan. 30, 2026 (GLOBE NEWSWIRE) — Alpine Banks of Colorado (OTCQX: ALPIB) (“Alpine” or the “Company”), the holding company for Alpine Bank (the “Bank”), today announced results (unaudited) for the fourth quarter and year ended December 31, 2025. The Company reported net income of $19.7 million, or $1.23 per basic Class A common share and basic Class B common share, for fourth quarter 2025. Highlights in fourth quarter 2025 and the year ended December 31, 2025, include:Basic earnings per Class A and Class B common share increased 6.4%, or $0.07, during fourth quarter 2025 as compared to third quarter 2025. Basic earnings per Class A and Class B common share increased 42.0%, or $1.30, during the 12 months ended December 31, 2025. Net interest margin for fourth quarter 2025 was 3.57% compared to 3.54% in...

HONG KONG, Jan. 30, 2026 (GLOBE NEWSWIRE) — DarkIris Inc. (Nasdaq: DKI) (the “Company” or “DarkIris”), a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games through various third-party digital storefronts, today announced its financial results for the fiscal year ended September 30, 2025. Mr. Zhifang Hong, Chief Executive Officer and Chairman of DarkIris, commented, “Fiscal year 2025 was a transformative year for DarkIris as we continued to develop, refine and iterate our games, successfully renewing and expanding our product portfolio. We delivered solid operating performance, with full-year revenue reaching $10.08 million, representing a year-over-year increase of 27.3%. This growth was primarily driven by sustained contributions from games launched in 2024, as well...

PALOS VERDES ESTATES, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) — Malaga Financial Corporation, “Company” (OTCIQ:MLGF), the parent company of Malaga Bank FSB, today reported that net income for the twelve months ended December 31, 2025 was $21,554,000 ($2.18 basic and fully diluted earnings per share) compared to $22,651,000 ($2.29 basic and fully diluted earnings per share, as adjusted for the stock dividend declared on November 13, 2025) for the twelve months ended December 31, 2024, a 5% decrease. Net income for the quarter ended December 31, 2025, was $5,123,000 ($0.52 basic and fully diluted earnings per share), a decrease of $189,000 or 4% from net income of $5,312,000 for the quarter ended December 31, 2024 ($0.54 basic and fully diluted earnings per share, as adjusted for the stock dividend declared on November 13, 2025)....

AIKEN, S.C., Jan. 30, 2026 (GLOBE NEWSWIRE) — Security Federal Corporation (the “Company”) (OTCBB: SFDL), the holding company for Security Federal Bank (the “Bank”), today announced earnings and financial results for the quarter and year ended December 31, 2025. The Company reported net income available to common shareholders of $3.9 million, or $1.24 per common share, for the quarter ended December 31, 2025, compared to $3.0 million, or $0.94 per common share, for the fourth quarter of 2024. Year-to-date net income available to common shareholders increased $3.3 million, to $12.0 million, or $3.80 per common share, for the year ended December 31, 2025, compared to $8.9 million, or $2.77 per common share, for the year ended December 31, 2024. The increase in both quarterly and year-to-date net income available to common shareholders...

Regulated information, Leuven, 30 January 2026 (17.40 hrs CET) Interim Financial Report 2025/2026 KBC Ancora recorded a profit of EUR 74.4 million in the first half of the financial year 2025/2026. This compared with a profit of EUR 73.9 million in the same period in the previous financial year. The result for the first six months of the financial year was determined chiefly by dividend income totalling EUR 77.5 million from the participating interest in KBC Group, operating costs of EUR 1.5 million and interest charges amounting to EUR 2.0 million. Abridged financial summaries and notes1 Results for the first half of financial year 2025/2026  1H FY (x EUR 1,000) 2025/2026per share(in EUR) 1H FY (x EUR 1,000) 2024/2025 per share(in EUR)Income 77,955 1.01 77,738 1.01Operating income 0 0.00 0 0.00Recurring financial income 77,955 1.01 77,738 1.01Expenses -3,597 -0.05 -3,805 -0.05Operating...

HANOVER, N.H., Jan. 30, 2026 (GLOBE NEWSWIRE) — Ledyard Financial Group, Inc. . (the “Company”, OTCQX®: LFGP), the holding company for Ledyard National Bank (the “Bank”), today reported quarterly net income per diluted share of $0.59, for the fourth quarter ended December 31, 2025, up 28% from $0.46 in the prior quarter, as core business activity continued to expand. Strong loan growth continued to drive balance sheet expansion, and wealth management revenue increased with growth in AUM. Reflecting the continued success of the company’s strategic investments, net income for the fourth quarter of 2025 was $2.0 million, up 47% over the comparable year-ago period and approaching a quarterly pace of earnings that nears the high points of previous years. For the full year, the Company reported net income of $6.0 million, or $1.81 per...

Melbourne, Australia, Jan. 30, 2026 (GLOBE NEWSWIRE) — Key Highlights from the QuarterACCENT Trial Success: The ACCENT trial, testing narmafotinib with gemcitabine and Abraxane®, continues to demonstrate that narmafotinib is well tolerated by patients whilst enhancing the effects of chemotherapy AMPLICITY Trial Initiation: The Phase 1b/2a AMPLICITY trial has started, combining narmafotinib with FOLFIRINOX chemotherapy, aiming to determine the optimal daily dose. Patient recruitment is ongoing in Melbourne and Sydney with US sites planned to open imminently Regulatory and Commercial Developments: Positive FDA feedback on dose optimization was received; a key patent for narmafotinib was granted; and Amplia successfully uplisted to the US-based OTCQB Venture Market, enhancing its investor reach Preclinical Studies: The second phase...

Fourth quarter diluted earnings per share (EPS) growth of 12%, or 14% on an adjusted basis (1) Fourth quarter operating ratio of 61.2%, or 60.1% on an adjusted basis (1) 2025 diluted EPS growth of 8%, or 7% on an adjusted basis (1) 2025 operating ratio of 61.9%, or 61.7% on an adjusted basis (1) Approximately 15 million shares repurchased in 2025 for approximately C$2 billion Capital program spending set at C$2.8 billion* for 2026, a decrease of C$500 million from 2025 (2)MONTREAL, Jan. 30, 2026 (GLOBE NEWSWIRE) — CN (TSX: CNR) (NYSE: CNI) today reported its financial and operating results for the fourth quarter and year ended December 31, 2025. “Our team delivered a strong fourth quarter and closed 2025 with disciplined execution and a relentless focus on capturing opportunities for our customers. I thank our railroaders...

HOUSTON, Jan. 30, 2026 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) today announced financial results for the quarter ended December 31, 2025. First Quarter 2026 Highlights and Recent DevelopmentsRevenue of $871 million for the first quarter of fiscal 2026, an increase of 16% compared with $750 million for the same quarter of fiscal 2025 Operating income of $97.7 million for the first quarter of fiscal 2026, an increase of 31% compared with $74.6 million for the same quarter of fiscal 2025 Net income attributable to IES of $91.4 million for the first quarter of fiscal 2026, an increase of 62% compared with $56.3 million for the same quarter of fiscal 2025, and diluted earnings per share attributable to common stockholders of $4.51 for the first quarter of fiscal 2026, compared with $2.72 for...